Navigation Links
Affitech in Medical Technology

Affitech-Discovered Anti-PS Antibodies in Development by Peregrine Pharmaceuticals Show Excellent Functionality in Preclinical Studies

... OSLO, Norway, April 28 /PRNewswire/ -- affitech AS, the human antibody therapeutics company, annou... libraries. The researchers from Peregrine, affitech and UT Southwestern Medical Center confirmed previ...al Center (Peregrine's academic collaborators) and affitech demonstrated in in vitro studies that immature den...

Data Presented at AACR Annual Meeting Show Anti-Tumor Activity of Peregrine's Fully Human Anti-PS Antibody in Prostate Cancer Model

... from UT Southwestern Medical Center in Dallas and affitech A/S reported that similar to bavituximab, the huma...ent and CEO of Peregrine. "Our collaboration with affitech to generate fully human anti-PS antibodies has pro...s developed through Peregrine's collaboration with affitech A/S. The studies were supported in part by a gran...

Studies Presented at AACR Annual Meeting Highlight Multiple Immunomodulatory Mechanisms of Peregrine's PS-Targeting Antibodies

...m of scientists from Peregrine Pharmaceuticals and affitech A/S used a fully human anti-PS antibody, PGN635, t...esearchers from UT Southwestern Medical Center and affitech demonstrated the ability of Peregrine's fully huma...e developed through Peregrine's collaboration with affitech A/S. The study by Dr. Huang, et al. was partly sup...

New Data Confirms That a Selective, Fully Human Anti-VEGF Antibody Being Developed by Peregrine is as Effective as Avastin(R) in Preclinical Cancer Models

...VEGF-induced angiogenesis. We look forward to further assessing R84 as a potential anti-angiogenic clinical candidate." Peregrine in association with affitech has filed a patent application for R84 with the United States Patent and Trademark Office to preserve the right to obtain patent protection in the Uni...

Data Presented at AACR Meeting Shows Peregrine's Selective Anti-VEGF Antibodies are as Effective as Avastin(R) in Preclinical Cancer Models

...human antibody R3 used in these studies was developed in collaboration with affitech AS of Norway. These studies were also supported in part by a postdoctoral f...ason B. Fleming, Rolf A. Brekken. UT Southwestern Medical Ctr., Dallas, TX, affitech AS, Oslo, Norway, Peregrine Pharmaceuticals Inc., Tustin, CA, UT-MD Anderso...

Positive Results Using Affitech-Identified Human Antibody That Blocks VEGF Binding to VEGF Receptor 2 in Preclinical Cancer Model Reported by Peregrine

... OSLO, Norway--(BUSINESS WIRE)--Apr 23, 2007 - affitech AS, the human antibody therapeutics company announ...n therapeutic antibody program " Editors notes affitech AS is a privately held human therapeutic antibody ...rrently in development were generated by CBAS(TM). affitech also sells its proprietary Protein L product line ...
Affitech in Biological News

Peregrine's PS-targeting antibodies highlighted in AACR Annual Meeting studies

...m of scientists from Peregrine Pharmaceuticals and affitech A/S used a fully human anti-PS antibody, PGN635, t...esearchers from UT Southwestern Medical Center and affitech demonstrated the ability of Peregrine's fully huma...e developed through Peregrine's collaboration with affitech A/S. The study by Dr. Huang, et al. was partly sup...
Affitech in Biological Technology

Pharmexa and Affitech to Combine Operations to Create a New Antibody Therapeutics Company

COPENHAGEN and OSLO, March 4 /PRNewswire/ -- Pharmexa A/S and Affitech AS announced today that they have entered into a conditional agreement to merge the two companies by means of a share for share acquisition by Pharmexa A/S of the private Norwegian company, Affitech AS. The purpose of the m...

Peregrine Pharmaceuticals Licenses Anti-VEGF Antibodies to Affitech

TUSTIN, Calif. and HORSHOLM, Denmark, July 22 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) and Affitech A/S (Nasdaq OMX: AFFI) today announced that they have entered into a licensing agreement for antibody therapeutic rights under Peregrine's ...

Affitech Acquires Pharmexa's Diabody Technology

... OSLO, Norway, October 28 /PRNewswire/ -- affitech AS, the human therapeutic antibody company, today ...ollows an exclusive license of the diabody IP that affitech obtained in 2007 from Pharmexa to carry out certai...s sub-licensing arrangements with third parties. affitech CEO Martin Welschof commented: "This is a key st...

Affitech Announces Second Milestone in Roche Antibody Discovery Collaboration

... OSLO, September 23 /PRNewswire/ -- affitech AS, the Norwegian human antibody therapeutics comp...ant antibodies against an unnamed oncology target. affitech has successfully used its MBAS (Molecule Based Ant...hof, Ph.D., Chief Executive Officer of Affitech. affitech and Roche entered into this collaboration in 2007 ...

Affitech Appoints Dr. Keith McCullagh as Chairman

... OSLO, Norway, September 9 /PRNewswire/ -- affitech AS, the Norwegian antibody therapeutics company, t...biopharmaceuticals market, but I am confident that affitech will benefit from his leadership and guidance. I w...novative potential new products. I look forward to affitech achieving several competitive commercial goals in ...

Affitech and Omeros Enter Into Antibody Discovery and Development Agreement

...ased clinical-stage biopharmaceutical company, and affitech AS, a Norwegian human antibody therapeutics compan... to advance the development of its MASP-2 program. affitech will apply its expansive human antibody libraries ... at Oxford University. Notes to editors: About affitech AS ...
Other Tags
(Date:9/30/2014)... Federally Qualified Health Centers (FQHCs) granted new ... at higher rates than other primary care practices ... according to results of a new 10-state University ... Medical Care . , Using data from a ... 2013, the investigators found that FQHCs community ...
(Date:9/30/2014)... 30, 2014 EverStryke , the permanent ... to SurvivalLife.com along with a free book and class all ... Shane Michaels, prompting an investigative review. , “Joe Marshall ... the survival and preparation niche, and this product is an ... classes and survival products that Joe offers on his website ...
(Date:9/30/2014)... Minn. (PRWEB) September 30, 2014 For ... to the apple orchard, pumpkin patch or annual festival. ... for fast-spreading viruses – like the respiratory infection Enterovirus ... in most children, a small percentage – especially children ... symptoms. Increased concern about the Enterovirus is prompting hospitals ...
(Date:9/30/2014)... TOWNSHIP, Mich. (PRWEB) September 30, 2014 ... chronic knee pain program of care that ... , His clinic—Johnson Chiropractic Neurology & Nutrition—applies ... on the knee. It also addresses sources of inflammation, ... well as the “neurokinetic chain” from the brain to ...
(Date:9/30/2014)... has made progress in reducing the stigma associated with ... post-traumatic stress disorder, but more improvement is still needed, ... efforts of both the Defense Department and the Veterans ... members still do not seek needed care for ... effort to promote treatment as a way to reduce ...
Breaking Medicine News(10 mins):Health News:Medicaid and Uninsured patients obtain new patient appointments most easily at FQHCs 2Health News:EverStryke: Review Exposes Joe Marshall’s Permanent Match Survival Product 2Health News:As Hospitals Combat Enterovirus Outbreaks, Patients and Families Turn to “Virtual Visits” with CaringBridge 2Health News:Newly Developed Program Eases Chronic Knee Pain without Surgery and in as Little as Two Days 2Health News:Newly Developed Program Eases Chronic Knee Pain without Surgery and in as Little as Two Days 3Health News:US military making progress reducing stigma tied to seeking help for mental illness 2Health News:US military making progress reducing stigma tied to seeking help for mental illness 3
(Date:9/30/2014)... 2014 Winners of The Economist,s prestigious Innovation ... to take place at the JW Marriott Hong Kong on Friday, ... will share their experiences and the lessons those hold for others. ... innovation over the past decade, will be presented at a ceremony ... summit. It will be the first time the ceremony has come ...
(Date:9/29/2014)... DC September 29, 2014 -- Plants have ... bacteria help the pants extract nutrients and defend ... pathogens from contaminating fruits and vegetables. Now, scientist ... bacteria inside of seeds; thus ensuring that sprouting ... from the University of Notre Dame, presented their ...
(Date:9/29/2014)... school? According to a new Food and Brand Lab ... can increase participation in the National School Lunch Program ... vegetables by 16%! , Chefs Move to Schools (CMTS), ... chefs with schools in order to provide nutrition instruction ... service workers. , A CMTS event was held in ...
Breaking Biology News(10 mins):Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 2Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 3Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 4Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 5Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 6Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 7Plants prepackage beneficial microbes in their seeds 2Chefs move to schools can increase school meal participation and vegetable intake among students 2
Other Contents